S. Cheenu Kappadath, PhD

CIO 2023-2 Feasibility of CT Based Tumor Dosimetry Using Multimodal Imageable Glass Eye90 Microspheres

Purpose: To demonstrate proof of concept for CT based tumor dosimetry after treatment of Hepatocellular Carcinoma (HCC) with multimodal imageable yttrium-90 (90Y) microspheres (Eye90 micr...

Amit Verma , DrPH, MPH;

David Dobrowski ;

Adam Kulp , PhD;

Eric Henry , PhD;

S. Cheenu Kappadath , PhD;

Aravind Arepally , MD;

Andrew Holden , MBChB;

11/01/2023

CIO 2022-3 Updated Clinical and Dosimetric Recommendations for Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma

Purpose: The TheraSphere Global Dosimetry Steering Committee (DSC) reconvened to update the clinical and dosimetric recommendations for the treatment of unresectable hepatocellular carcin...

Siddharth A. Padia , MD;

S. Cheenu Kappadath , PhD;

Riad Salem , MD, MBA;

Bruno Sangro , MD, PhD;

Edward Kim , MD;

Daniel Sze , MD, PhD;

Marnix Lam ;

Carlo Chiesa ;

Paul Haste ;

Beau Toskich ;

Kirk Fowers ;

Joseph M. Herman ;